Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-quinoline-6-carboxamide monohydrate

EU orphan designation number: EU/3/13/1120   
Active ingredient: 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-quinoline-6-carboxamide monohydrate
Indication: Treatment of glioma
Sponsor: Eli Lilly Nederland B.V.
Grootslag 1-5, NL-3991 RA Houten, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/05/2013 Centralised Orphan - Designation EMA/OD/170/12 (2013)2557 of 26/04/2013